<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is often considered to arise from a clonal stem-like population of cells, which is potentially responsible for its poor prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>Transforming growth factor β (TGF-β) and Notch signaling pathways play important roles in regulating self-renewal of stem cells and cell-fate determination </plain></SENT>
<SENT sid="2" pm="."><plain>Both pathways are frequently implicated in gastrointestinal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>However, their contributions to esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> remain unclear </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We evaluated TGF-β and Notch signaling components in <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissues and cell lines via immunohistochemical analysis and immunoblotting; Hes-1 transcription was assayed using a Hes-1 luciferase reporter </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: We observed loss of Smad4 (P&lt;.05) and β2 spectrin (β2SP) (P&lt;.01) in 5/10 <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and 17/22 <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissue sections </plain></SENT>
<SENT sid="6" pm="."><plain>Concomitantly, dramatically raised levels of Notch signaling components Hes1 and Jagged1 occurred in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissues and cell lines compared with <z:mpath ids='MPATH_458'>normal</z:mpath> tissues </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus, Oct3/4-positive cells are located in the basal layer (2-3 per cluster), representing a pool of progenitor cells </plain></SENT>
<SENT sid="8" pm="."><plain>We observed an expansion of this pool of Oct3/4 positive cells in esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (15 per cluster) </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, a panel of SOXs proteins documented for stem cell markers exhibit increased expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, indicating expansion of putative <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells </plain></SENT>
<SENT sid="10" pm="."><plain>Finally, we observed growth inhibition in BE3 cells with a γ-secretase inhibitor, but not in SKGT-4 cells </plain></SENT>
<SENT sid="11" pm="."><plain>Unlike SKGT-4 cells, BE3 cells have activated Notch signaling with disruption of TGF-β signaling </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Our findings demonstrated a potential therapeutic value for targeted therapy in esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in the setting of loss of β2SP/TGF-β with concomitant constitutively active Notch signaling </plain></SENT>
</text></document>